Healthcare - Biotechnology - NASDAQ - US
$ 26.64
-9.6 %
$ 2.3 B
Market Cap
-11.43
P/E
BALANCE SHEET
649 M
ASSETS
28.2 M
LIABILITIES
621 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
IDEAYA Biosciences, Inc.
| Current Assets | 533 M |
| Cash & Short-Term Investments | 525 M |
| Receivables | 18 K |
| Other Current Assets | 7.5 M |
| Non-Current Assets | 117 M |
| Long-Term Investments | 107 M |
| PP&E | 8.41 M |
| Other Non-Current Assets | 782 K |
| Current Liabilities | 27.1 M |
| Accounts Payable | 6.6 M |
| Short-Term Debt | 3.49 M |
| Other Current Liabilities | 17 M |
| Non-Current Liabilities | 1.12 M |
| Long-Term Debt | 1.12 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 157.0 | 68.6 | 92.0 | 72.0 | 34.1 | 20.5 | 6.0 |
| Short Term Investments | 368.1 | 296.2 | 154.7 | 211.5 | 64.9 | 69.5 | 7.2 |
| Receivables | 18 K | 0.2 | 1.1 | 1.9 | 0 | 0 | 0 |
| Inventory | 0 | (8.3) | (121.3) | 0 | 0 | 0 | 0 |
| Other Current Assets | 7.5 | 5.4 | 6.2 | 6.3 | 5.4 | 0.7 | 0.4 |
| Total Current Assets | 532.6 | 370.5 | 251.0 | 288.6 | 100.5 | 90.7 | 13.6 |
| PP&E | 8.4 | 9.0 | 8.7 | 9.5 | 9.7 | 5.2 | 3.7 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 107.5 | 8.3 | 121.3 | 0.1 | 1.5 | 0.1 | 71 K |
| Other Long Term Assets | 0.8 | 0.2 | 0.4 | 82 K | 1.3 | 0.6 | 89 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 649.3 | 388.0 | 381.3 | 298.3 | 113.0 | 96.5 | 17.5 |
| LIABILITIES | |||||||
| Accounts Payable | 6.6 | 4.3 | 2.1 | 1.0 | 0.7 | 1.4 | 0.7 |
| Short Term Debt | 3.5 | 3.7 | 3.4 | 3.1 | 1.1 | 0 | 0 |
| Other Current Liabilities | 17.0 | 25.0 | 17.3 | 7.0 | 5.1 | 3.7 | 1.5 |
| Total Current Liabilities | 27.1 | 31.7 | 45.2 | 38.6 | 6.9 | 5.4 | 2.4 |
| Long Term Debt | 1.1 | 1.6 | 3.5 | 5.2 | 0 | 0 | 3.2 |
| Deferred Tax Income | 0 | (5.2) | (31.2) | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 12 K | 5.7 | 140.1 | 27.6 |
| Total Liabilities | 28.2 | 388.0 | 381.3 | 298.3 | 113.0 | 145.5 | 33.2 |
| EQUITY | |||||||
| Common Stock | 7 K | 5 K | 4 K | 3 K | 2 K | 1 K | 1 K |
| Retained Earnings | (348.4) | (235.4) | (176.7) | (127.0) | (92.5) | (50.5) | (16.2) |
| Other Accumulative Comprehensive Income/Loss | 0.6 | (2.9) | (0.7) | 7 K | 65 K | 31 K | 1 K |
| Total Equity | 621.1 | 349.5 | 301.5 | 198.3 | 100.4 | (48.9) | (15.7) |
| Total Liabilities and Equity | 649.3 | 388.0 | 381.3 | 298.3 | 113.0 | 96.5 | 17.5 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 57.5 | 41.4 | 35.3 | 24.7 | 20.2 | 14.2 | 14.2 |